Show PDB file:   
         Plain Text   HTML   (compressed file size)
QuickSearch:   
by PDB,NDB,UniProt,PROSITE Code or Search Term(s)  
(-)Asym./Biol. Unit
(-)Asym./Biol. Unit - sites
collapse expand < >
Image Asym./Biol. Unit
Asym./Biol. Unit  (Jmol Viewer)
Image Asym./Biol. Unit - sites
Asym./Biol. Unit - sites  (Jmol Viewer)

(-) Description

Title :  CRYSTAL STRUCTURE OF HUMAN MATRIX METALLOPROTEINASE MMP9 (GELATINASE B).
 
Authors :  P. A. Elkins, Y. S. Ho, W. W. Smith, C. A. Janson, K. J. D'Alessio, M. S. Mcqueney, M. D. Cummings, A. M. Romanic
Date :  11 Mar 02  (Deposition) - 03 Jul 02  (Release) - 24 Feb 09  (Revision)
Method :  X-RAY DIFFRACTION
Resolution :  2.50
Chains :  Asym./Biol. Unit :  A
Keywords :  Twisted Beta Sheet Flanked By Helices, Hydrolase (Keyword Search: [Gene Ontology, PubMed, Web (Google))
 
Reference :  P. A. Elkins, Y. S. Ho, W. W. Smith, C. A. Janson, K. J. D'Alessio, M. S. Mcqueney, M. D. Cummings, A. M. Romanic
Structure Of The C-Terminally Truncated Human Prommp9, A Gelatin-Binding Matrix Metalloproteinase.
Acta Crystallogr. , Sect. D V. 58 1182 2002
PubMed-ID: 12077439  |  Reference-DOI: 10.1107/S0907444902007849
(for further references see the PDB file header)

(-) Compounds

Molecule 1 - MATRIX METALLOPROTEINASE-9
    ChainsA
    EC Number3.4.24.35
    EngineeredYES
    Expression SystemESCHERICHIA COLI
    Expression System StrainBLR (DE3)
    Expression System Taxid562
    FragmentPRO-FORM WITH C-TERMINAL DOMAIN TRUNCATED
    Organism CommonHUMAN
    Organism ScientificHOMO SAPIENS
    Organism Taxid9606
    SynonymMMP9, GELATINASE B, GELB

 Structural Features

(-) Chains, Units

  1
Asymmetric/Biological Unit A

Summary Information (see also Sequences/Alignments below)

(-) Ligands, Modified Residues, Ions  (2, 5)

Asymmetric/Biological Unit (2, 5)
No.NameCountTypeFull Name
1CA3Ligand/IonCALCIUM ION
2ZN2Ligand/IonZINC ION

(-) Sites  (5, 5)

Asymmetric Unit (5, 5)
No.NameEvidenceResiduesDescription
1AC1SOFTWARECYS A:99 , HIS A:401 , HIS A:405 , HIS A:411BINDING SITE FOR RESIDUE ZN A 500
2AC2SOFTWAREHIS A:175 , ASP A:177 , HIS A:190 , HIS A:203BINDING SITE FOR RESIDUE ZN A 501
3AC3SOFTWAREASP A:182 , GLY A:183 , GLY A:186 , LEU A:187 , ASP A:205 , GLU A:208BINDING SITE FOR RESIDUE CA A 502
4AC4SOFTWAREASP A:131 , ASP A:206 , GLU A:208 , HOH A:1054BINDING SITE FOR RESIDUE CA A 503
5AC5SOFTWAREALA A:164 , ASP A:165 , GLY A:197 , GLN A:199 , ASP A:201 , HOH A:1052 , HOH A:1174BINDING SITE FOR RESIDUE CA A 504

(-) SS Bonds  (6, 6)

Asymmetric/Biological Unit
No.Residues
1A:230 -A:256
2A:244 -A:271
3A:288 -A:314
4A:302 -A:329
5A:347 -A:373
6A:361 -A:388

(-) Cis Peptide Bonds  (3, 3)

Asymmetric/Biological Unit
No.Residues
1Phe A:232 -Pro A:233
2Phe A:290 -Pro A:291
3Phe A:349 -Pro A:350

 Sequence-Structure Mapping

(-) SAPs(SNPs)/Variants  (5, 5)

Asymmetric/Biological Unit (5, 5)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
1UniProtVAR_037004N38SMMP9_HUMANPolymorphism41427445AN38S
2UniProtVAR_013781E82KMMP9_HUMANPolymorphism1805089AE82K
3UniProtVAR_020054N127KMMP9_HUMANPolymorphism3918252AN127K
4UniProtVAR_025165R239HMMP9_HUMANPolymorphism28763886AR239H
5UniProtVAR_013782Q279RMMP9_HUMANPolymorphism17576AR279R

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

(-) PROSITE Motifs  (4, 8)

Asymmetric/Biological Unit (4, 8)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1CYSTEINE_SWITCHPS00546 Matrixins cysteine switch.MMP9_HUMAN97-104  1A:97-104
2FN2_2PS51092 Fibronectin type-II collagen-binding domain profile.MMP9_HUMAN225-273
283-331
342-390
  3A:225-273
A:283-331
A:342-390
3FN2_1PS00023 Fibronectin type-II collagen-binding domain signature.MMP9_HUMAN230-271
288-329
347-388
  3A:230-271
A:288-329
A:347-388
4ZINC_PROTEASEPS00142 Neutral zinc metallopeptidases, zinc-binding region signature.MMP9_HUMAN398-407  1A:398-407

(-) Exons   (9, 9)

Asymmetric/Biological Unit (9, 9)
 ENSEMBLUniProtKBPDB
No.Transcript IDExonExon IDGenome LocationLengthIDLocationLengthCountLocationLength
1.1ENST000003723301ENSE00001457585chr20:44637547-44637703157MMP9_HUMAN1-46461A:29-4618
1.2ENST000003723302ENSE00000662462chr20:44638505-44638737233MMP9_HUMAN47-124781A:47-124 (gaps)78
1.3ENST000003723303ENSE00000845116chr20:44639122-44639270149MMP9_HUMAN124-174511A:124-17451
1.4ENST000003723304ENSE00000845117chr20:44639561-44639689129MMP9_HUMAN174-217441A:174-21744
1.5ENST000003723305ENSE00000845118chr20:44639782-44639955174MMP9_HUMAN217-275591A:217-27559
1.6ENST000003723306ENSE00000845119chr20:44640213-44640386174MMP9_HUMAN275-333591A:275-33359
1.7ENST000003723307ENSE00000845120chr20:44640776-44640952177MMP9_HUMAN333-392601A:333-39260
1.8ENST000003723308ENSE00000845121chr20:44641066-44641221156MMP9_HUMAN392-444531A:392-44453
1.9ENST000003723309ENSE00000845122chr20:44641894-44642173280MMP9_HUMAN444-537941A:444-4441
1.10ENST0000037233010ENSE00000845123chr20:44642296-44642435140MMP9_HUMAN537-584480--
1.11ENST0000037233011ENSE00000845124chr20:44642763-44642913151MMP9_HUMAN584-634510--
1.12ENST0000037233012ENSE00000845125chr20:44643010-44643113104MMP9_HUMAN634-669360--
1.13ENST0000037233013ENSE00001457551chr20:44644889-44645200312MMP9_HUMAN669-707390--

(-) Sequences/Alignments

Asymmetric/Biological Unit
   Reformat: Number of residues per line =  ('0' or empty: single-line sequence representation)
  Number of residues per labelling interval =   
  UniProt sequence: complete  aligned part    
   Show mapping: SCOP domains CATH domains Pfam domains Secondary structure (by author)
SAPs(SNPs) PROSITE motifs Exons
(details for a mapped element are shown in a popup box when the mouse pointer rests over it)
Chain A from PDB  Type:PROTEIN  Length:405
 aligned with MMP9_HUMAN | P14780 from UniProtKB/Swiss-Prot  Length:707

    Alignment length:416
                                    38        48        58        68        78        88        98       108       118       128       138       148       158       168       178       188       198       208       218       228       238       248       258       268       278       288       298       308       318       328       338       348       358       368       378       388       398       408       418       428       438      
           MMP9_HUMAN    29 VLFPGDLRTNLTDRQLAEEYLYRYGYTRVAEMRGESKSLGPALLLLQKQLSLPETGELDSATLKAMRTPRCGVPDLGRFQTFEGDLKWHHHNITYWIQNYSEDLPRAVIDDAFARAFALWSAVTPLTFTRVYSRDADIVIQFGVAEHGDGYPFDGKDGLLAHAFPPGPGIQGDAHFDDDELWSLGKGVVVPTRFGNADGAACHFPFIFEGRSYSACTTDGRSDGLPWCSTTANYDTDDRFGFCPSERLYTQDGNADGKPCQFPFIFQGQSYSACTTDGRSDGYRWCATTANYDRDKLFGFCPTRADSTVMGGNSAGELCVFPFTFLGKEYSTCTSEGRGDGRLWCATTSNFDSDKKWGFCPDQGYSLFLVAAHEFGHALGLDHSSVPEALMYPMYRFTEGPPLHKDDVNGIRHLYG 444
               SCOP domains d1l6ja1 A:29-105 Gelatinase            B (MMP-9)                             d1l6ja2 A:106-215,A:391-444 Gelatinase B (MMP-9)                                                              d1l6ja3 A:216-274 Gelatinase B (MMP-9) type II modules     d1l6ja4 A:275-331 Gelatinase B (MMP-9) type II modules   d1l6ja5 A:332-390 Gelatinase B (MMP-9) type II modules     d1l6ja2 A:106-215,A:391-444 Gelatinase B (MMP-9)       SCOP domains
               CATH domains -----------1l6jA01 A:40-104            Muramoyl-pentapeptide Carboxypeptidas1l6jA02 A:105-215,A:390-444 Collagenase (Catalytic Domain)                                                     -1l6jA03 A:217-273  [code=2.10.10.10, no name defined]    1l6jA04 A:274-333  [code=2.10.10.10, no name defined]       1l6jA05 A:334-389  [code=2.10.10.10, no name defined]   1l6jA02 A:105-215,A:390-444                             CATH domains
           Pfam domains (1) ---------PG_binding_1-1l6jA           01 A:38-94                  --------------------Peptidase_M10-1l6jA02 A:115-444                                                                                                                                                                                                                                                                                                            Pfam domains (1)
           Pfam domains (2) ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------fn2-1l6jA03 A:347-388                     -------------------------------------------------------- Pfam domains (2)
           Pfam domains (3) ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------fn2-1l6jA04 A:347-388                     -------------------------------------------------------- Pfam domains (3)
           Pfam domains (4) ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------fn2-1l6jA05 A:347-388                     -------------------------------------------------------- Pfam domains (4)
         Sec.struct. author ...........hhhhhhhhhhhhh...-----------hhhhhhhhhhhhh.......hhhhhhhhh........................eeeeee.......hhhhhhhhhhhhhhhhhhh...eeeee......eeeeee.................eee..........eeee....ee......................ee....ee.............eee...hhhhhh.eee.....................eee..eee.............eee...hhhhhh.eee...hhhhh..............eee..eee.............eee...hhhhhh.eee.....eehhhhhhhhhhhhh........................hhhhhhhhhhhh. Sec.struct. author
                 SAPs(SNPs) ---------S-------------------------------------------K--------------------------------------------K---------------------------------------------------------------------------------------------------------------H---------------------------------------R--------------------------------------------------------------------------------------------------------------------------------------------------------------------- SAPs(SNPs)
                PROSITE (1) --------------------------------------------------------------------CYSTEINE------------------------------------------------------------------------------------------------------------------------FN2_2  PDB: A:225-273 UniProt: 225-273           ---------FN2_2  PDB: A:283-331 UniProt: 283-331           ----------FN2_2  PDB: A:342-390 UniProt: 342-390           -------ZINC_PROTE------------------------------------- PROSITE (1)
                PROSITE (2) ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------FN2_1  PDB: A:230-271 UniProt: 230-271    ----------------FN2_1  PDB: A:288-329 UniProt: 288-329    -----------------FN2_1  PDB: A:347-388 UniProt: 347-388    -------------------------------------------------------- PROSITE (2)
           Transcript 1 (1) Exon 1.1          Exon 1.2  PDB: A:47-124 (gaps) UniProt: 47-124                                -------------------------------------------------Exon 1.4  PDB: A:174-217 UniProt: 174-217   ---------------------------------------------------------Exon 1.6  PDB: A:275-333 UniProt: 275-333                  ----------------------------------------------------------Exon 1.8  PDB: A:392-444 UniProt: 392-444             Transcript 1 (1)
           Transcript 1 (2) -----------------------------------------------------------------------------------------------Exon 1.3  PDB: A:124-174 UniProt: 124-174          ------------------------------------------Exon 1.5  PDB: A:217-275 UniProt: 217-275                  ---------------------------------------------------------Exon 1.7  PDB: A:333-392 UniProt: 333-392                   ---------------------------------------------------1 Transcript 1 (2)
                 1l6j A  29 VLFPGDLRTNLTDRQLAEEYLYRYGYT-----------LGPALLLLQKQLSLPETGELDSATLKAMRTPRCGVPDLGRFQTFEGDLKWHHHNITYWIQNYSEDLPRAVIDDAFARAFALWSAVTPLTFTRVYSRDADIVIQFGVAEHGDGYPFDGKDGLLAHAFPPGPGIQGDAHFDDDELWSLGKGVVVPTRFGNADGAACHFPFIFEGRSYSACTTDGRSDGLPWCSTTANYDTDDRFGFCPSERLYTRDGNADGKPCQFPFIFQGQSYSACTTDGRSDGYRWCATTANYDRDKLFGFCPTRADSTVMGGNSAGELCVFPFTFLGKEYSTCTSEGRGDGRLWCATTSNFDSDKKWGFCPDQGYSLFLVAAHEFGHALGLDHSSVPEALMYPMYRFTEGPPLHKDDVNGIRHLYG 444
                                    38        48      |  -        68        78        88        98       108       118       128       138       148       158       168       178       188       198       208       218       228       238       248       258       268       278       288       298       308       318       328       338       348       358       368       378       388       398       408       418       428       438      
                                                     55          67                                                                                                                                                                                                                                                                                                                                                                                         

   Legend:   → Mismatch (orange background)
  - → Gap (green background, '-', border residues have a numbering label)
    → Modified Residue (blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
  x → Chemical Group (purple background, 'x', labelled with number + name, e.g. ACE or NH2)
  extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '|'

 Classification and Annotation

(-) SCOP Domains  (3, 5)

Asymmetric/Biological Unit

(-) CATH Domains  (3, 5)

Asymmetric/Biological Unit
(-)
Class: Alpha Beta (26913)
(-)
Class: Mainly Beta (13760)

(-) Pfam Domains  (3, 5)

Asymmetric/Biological Unit
(-)
Clan: PGBD (5)
(-)
Family: fn2 (6)
3afn2-1l6jA03A:347-388
3bfn2-1l6jA04A:347-388
3cfn2-1l6jA05A:347-388

(-) Gene Ontology  (38, 38)

Asymmetric/Biological Unit(hide GO term definitions)
Chain A   (MMP9_HUMAN | P14780)
molecular function
    GO:0005518    collagen binding    Interacting selectively and non-covalently with collagen, a group of fibrous proteins of very high tensile strength that form the main component of connective tissue in animals. Collagen is highly enriched in glycine (some regions are 33% glycine) and proline, occurring predominantly as 3-hydroxyproline (about 20%).
    GO:0004175    endopeptidase activity    Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain.
    GO:0016787    hydrolase activity    Catalysis of the hydrolysis of various bonds, e.g. C-O, C-N, C-C, phosphoric anhydride bonds, etc. Hydrolase is the systematic name for any enzyme of EC class 3.
    GO:0042802    identical protein binding    Interacting selectively and non-covalently with an identical protein or proteins.
    GO:0046872    metal ion binding    Interacting selectively and non-covalently with any metal ion.
    GO:0004222    metalloendopeptidase activity    Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain by a mechanism in which water acts as a nucleophile, one or two metal ions hold the water molecule in place, and charged amino acid side chains are ligands for the metal ions.
    GO:0008237    metallopeptidase activity    Catalysis of the hydrolysis of peptide bonds by a mechanism in which water acts as a nucleophile, one or two metal ions hold the water molecule in place, and charged amino acid side chains are ligands for the metal ions.
    GO:0008233    peptidase activity    Catalysis of the hydrolysis of a peptide bond. A peptide bond is a covalent bond formed when the carbon atom from the carboxyl group of one amino acid shares electrons with the nitrogen atom from the amino group of a second amino acid.
    GO:0005515    protein binding    Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
    GO:0004252    serine-type endopeptidase activity    Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain by a catalytic mechanism that involves a catalytic triad consisting of a serine nucleophile that is activated by a proton relay involving an acidic residue (e.g. aspartate or glutamate) and a basic residue (usually histidine).
    GO:0008270    zinc ion binding    Interacting selectively and non-covalently with zinc (Zn) ions.
biological process
    GO:0030574    collagen catabolic process    The proteolytic chemical reactions and pathways resulting in the breakdown of collagen in the extracellular matrix, usually carried out by proteases secreted by nearby cells.
    GO:0007566    embryo implantation    Attachment of the blastocyst to the uterine lining.
    GO:0035987    endodermal cell differentiation    The process in which a relatively unspecialized cell acquires the specialized features of an endoderm cell, a cell of the inner of the three germ layers of the embryo.
    GO:0048013    ephrin receptor signaling pathway    The series of molecular signals generated as a consequence of an ephrin receptor binding to an ephrin.
    GO:0022617    extracellular matrix disassembly    A process that results in the breakdown of the extracellular matrix.
    GO:0030198    extracellular matrix organization    A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of an extracellular matrix.
    GO:0050900    leukocyte migration    The movement of a leukocyte within or between different tissues and organs of the body.
    GO:0030225    macrophage differentiation    The process in which a relatively unspecialized monocyte acquires the specialized features of a macrophage.
    GO:0043066    negative regulation of apoptotic process    Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
    GO:2001258    negative regulation of cation channel activity    Any process that stops, prevents or reduces the frequency, rate or extent of cation channel activity.
    GO:2001268    negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway    Any process that stops, prevents or reduces the frequency, rate or extent of cysteine-type endopeptidase activity involved in apoptotic signaling pathway.
    GO:2001243    negative regulation of intrinsic apoptotic signaling pathway    Any process that stops, prevents or reduces the frequency, rate or extent of intrinsic apoptotic signaling pathway.
    GO:0001503    ossification    The formation of bone or of a bony substance, or the conversion of fibrous tissue or of cartilage into bone or a bony substance.
    GO:0043388    positive regulation of DNA binding    Any process that increases the frequency, rate or extent of DNA binding. DNA binding is any process in which a gene product interacts selectively with DNA (deoxyribonucleic acid).
    GO:0043065    positive regulation of apoptotic process    Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process.
    GO:0045742    positive regulation of epidermal growth factor receptor signaling pathway    Any process that activates or increases the frequency, rate or extent of epidermal growth factor receptor signaling pathway activity.
    GO:0051549    positive regulation of keratinocyte migration    Any process that activates or increases the frequency, rate or extent of keratinocyte migration.
    GO:0001934    positive regulation of protein phosphorylation    Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to amino acids within a protein.
    GO:1900122    positive regulation of receptor binding    Any process that activates or increases the frequency, rate or extent of a protein or other molecule binding to a receptor.
    GO:0090200    positive regulation of release of cytochrome c from mitochondria    Any process that increases the rate, frequency or extent of release of cytochrome c from mitochondria, the process in which cytochrome c is enabled to move from the mitochondrial intermembrane space into the cytosol, which is an early step in apoptosis and leads to caspase activation.
    GO:0006508    proteolysis    The hydrolysis of proteins into smaller polypeptides and/or amino acids by cleavage of their peptide bonds.
    GO:0001501    skeletal system development    The process whose specific outcome is the progression of the skeleton over time, from its formation to the mature structure. The skeleton is the bony framework of the body in vertebrates (endoskeleton) or the hard outer envelope of insects (exoskeleton or dermoskeleton).
cellular component
    GO:0070062    extracellular exosome    A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
    GO:0031012    extracellular matrix    A structure lying external to one or more cells, which provides structural support for cells or tissues.
    GO:0005576    extracellular region    The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
    GO:0005615    extracellular space    That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
    GO:0005578    proteinaceous extracellular matrix    A layer consisting mainly of proteins (especially collagen) and glycosaminoglycans (mostly as proteoglycans) that forms a sheet underlying or overlying cells such as endothelial and epithelial cells. The proteins are secreted by cells in the vicinity. An example of this component is found in Mus musculus.

 Visualization

(-) Interactive Views

Asymmetric/Biological Unit
  Complete Structure
    Jena3D(integrated viewing of ligand, site, SAP, PROSITE, SCOP information)
    WebMol | AstexViewer[tm]@PDBe
(Java Applets, require no local installation except for Java; loading may be slow)
    STRAP
(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    RasMol
(require local installation)
    Molscript (VRML)
(requires installation of a VRML viewer; select preferred view via VRML and generate a mono or stereo PDF format file)
 
  Ligands, Modified Residues, Ions
    CA  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    ZN  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
 
  Sites
    AC1  [ RasMol ]  +environment [ RasMol ]
    AC2  [ RasMol ]  +environment [ RasMol ]
    AC3  [ RasMol ]  +environment [ RasMol ]
    AC4  [ RasMol ]  +environment [ RasMol ]
    AC5  [ RasMol ]  +environment [ RasMol ]
 
  Cis Peptide Bonds
    Phe A:232 - Pro A:233   [ RasMol ]  
    Phe A:290 - Pro A:291   [ RasMol ]  
    Phe A:349 - Pro A:350   [ RasMol ]  
 

(-) Still Images

Jmol
  protein: cartoon or spacefill or dots and stick; nucleic acid: cartoon and stick; ligands: spacefill; active site: stick
Molscript
  protein, nucleic acid: cartoon; ligands: spacefill; active site: ball and stick

 Databases and Analysis Tools

(-) Databases

Access by PDB/NDB ID
  1l6j
    Family and Domain InformationProDom | SYSTERS
    General Structural InformationGlycoscienceDB | MMDB | NDB | OCA | PDB | PDBe | PDBj | PDBsum | PDBWiki | PQS | PROTEOPEDIA
    Orientation in MembranesOPM
    Protein SurfaceSURFACE
    Secondary StructureDSSP (structure derived) | HSSP (homology derived)
    Structural GenomicsGeneCensus
    Structural NeighboursCE | VAST
    Structure ClassificationCATH | Dali | SCOP
    Validation and Original DataBMRB Data View | BMRB Restraints Grid | EDS | PROCHECK | RECOORD | WHAT_CHECK
 
Access by UniProt ID/Accession number
  MMP9_HUMAN | P14780
    Comparative Protein Structure ModelsModBase
    Genomic InformationEnsembl
    Protein-protein InteractionDIP
    Sequence, Family and Domain InformationInterPro | Pfam | SMART | UniProtKB/SwissProt
 
Access by Enzyme Classificator   (EC Number)
  3.4.24.35
    General Enzyme InformationBRENDA | EC-PDB | Enzyme | IntEnz
    PathwayKEGG | MetaCyc
 
Access by Disease Identifier   (MIM ID)
  (no 'MIM ID' available)
    Disease InformationOMIM
 
Access by GenAge ID
  (no 'GenAge ID' available)
    Age Related InformationGenAge

(-) Analysis Tools

Access by PDB/NDB ID
    Domain InformationXDom
    Interatomic Contacts of Structural UnitsCSU
    Ligand-protein ContactsLPC
    Protein CavitiescastP
    Sequence and Secondary StructurePDBCartoon
    Structure AlignmentSTRAP(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    Structure and Sequence BrowserSTING
 
Access by UniProt ID/Accession number
  MMP9_HUMAN | P14780
    Protein Disorder PredictionDisEMBL | FoldIndex | GLOBPLOT (for more information see DisProt)

 Related Entries

(-) Entries Sharing at Least One Protein Chain (UniProt ID)

UniProtKB/Swiss-Prot
        MMP9_HUMAN | P147801gkc 1gkd 1itv 1lkg 2ovx 2ovz 2ow0 2ow1 2ow2 4h1q 4h2e 4h3x 4h82 4hma 4jij 4jqg 4wzv 4xct 5cuh 5i12 5th6 5th9

(-) Related Entries Specified in the PDB File

(no "Related Entries Specified in the PDB File" available for 1L6J)